Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod — Stella

Recruiting

Back to Myasthenia Gravis Crisis trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

University of Colorado, Aurora, Colorado

Key details

Phase

Post-approval study

Sponsor

University of Colorado, Denver

Collaborators

argenx

Enrollment target

~20 participants

Started

March 2025

Primary completion

December 2026

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov